May 13, 2021
…the coordination of complex therapies and the team-based care led by Dr. Joseph A. Califano III, director of the newly named Hanna and Mark Gleiberman Head and Neck Cancer Center at UC San Diego Health. The Gleiberman Head and Neck Cancer Center, led by its director, Joseph A. Califano III,…
October 18, 2018
Steffanie Strathdee, PhD, associate dean of global health sciences at University of California San Diego School of Medicine, was named today one of TIME magazine’s 50 Most Influential People in Health Care for 2018, which identifies people who “have changed the state of health care in America this year, and…
December 1, 2017
The Independent Citizens Oversight Committee of the California Institute for Regenerative Medicine (CIRM) unanimously approved yesterday two grants worth a total of almost $8 million to University of California San Diego School of Medicine researchers investigating novel stem cell-based treatments for acute myeloid leukemia or AML.
February 3, 2014
Researchers at the University of California, San Diego School of Medicine have identified a protein critical to hematopoietic stem cell function and blood formation. The finding has potential as a new target for treating leukemia because cancer stem cells rely upon the same protein to regulate and sustain their growth.
September 29, 2014
Researchers have found that a key neuronal protein called alpha-synuclein normally gathers in synapses, where aggregates of it help regulate neurotransmissions. In overabundance, though, a-synuclein can choke off communication altogether, leading to neuronal death and related diseases.
July 26, 2019
The Luau and Legends of Surfing Invitational brings together over 500 surfers, doctors and cancer survivors at Scripps Pier to catch a few waves, enjoy food and drink and raise money for cancer research.
June 30, 2016
Using a database of human tumor genomic data, researchers at the University of California San Diego, School of Medicine and Moores Cancer Center discovered that mutation hotspots known as kataegis are a positive marker in breast cancer — patients with kataegis have less invasive tumors and better prognoses. The study,…
July 6, 2015
Using human tumor samples and mouse models, researchers at University of California, San Diego School of Medicine and Moores Cancer Center discovered that cancer stem cell properties are determined by epigenetic changes — chemical modifications cells use to control which genes are turned on or off.
August 21, 2019
University of California San Diego School of Medicine researchers identified a new therapeutic approach in mouse models that halts drug resistance and cancer progression by using an antibody that induces the immune system via macrophages to seek and kill cancer cells.
August 28, 2015
Four University of California, San Diego School of Medicine researchers have been selected to receive the newly established National Cancer Institute (NCI) Outstanding Investigator Award. The multi-million dollar awards fund new projects that have an unusual potential in cancer research over seven years.
